Clinical Leadership Founder and Medical Director Dr. Glen Brooks is a recognized leader in Ketamine Infusion Therapy, offering a strong physician-led credibility hook for partnerships, referrals, and educational collaborations.

Treatment Expansion Recently launched a Ketamine for Alcohol Dependence program, signaling openness to programmatic growth and new referral opportunities across comorbidity-focused care pathways.

Scale and Reach Small to mid-size operation with 11-50 employees and a patient base exceeding 8,000 over 12 years, presenting a scalable service model that can be complemented with ancillary services or regional partnerships.

Digital and Ads Active digital marketing stack (Google Ads, Reddit Ads, WordPress, Google Cloud) and a strong online presence, offering opportunities for co-marketing, joint campaigns, or technology-enabled patient funnels.

Financial and Market Pace Revenue under $1M indicates room for strategic partner alignment with payer negotiations, service line expansion, or bundled offerings to accelerate growth and reach in mental health and addiction treatment markets.